{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-023195","form_type":"8-K","ticker":"SNYR","cik":"0001562733","company_name":"Synergy CHC Corp.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.444947+00:00","generated_at":"2026-05-15T22:14:51.296914+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Gravity Pharma terminates $2.9M brand license agreement ab initio for Synergy CHC","bullets":["Gravity Pharma terminated Brand License Agreement ab initio for FOCUSfactor and Flat Tummy Co. products in UAE & Turkey.","Agreement provided exclusive license for $2.9M aggregate fee previously recognized as revenue by Synergy CHC.","Company continues pursuing registration and marketing of licensed IP in the Territory."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-023195","json":"https://secwatch.observer/filing/0001213900-26-023195.json","markdown":"https://secwatch.observer/filing/0001213900-26-023195.md","text":"https://secwatch.observer/filing/0001213900-26-023195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026023195/0001213900-26-023195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026023195/ea0279861-8k_synergy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:14:51.296914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}